Latest Regulatory Impact News

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

Turners Automotive Group has reported a record FY25 performance, with net profit after tax rising 17% to $38.6 million and dividends increasing 14% to 29.0 cents per share, showcasing resilience amid challenging economic conditions.

Webjet Group Limited reported a stable FY25 EBITDA of $39.4 million despite a 7% decline in bookings driven by soft domestic flight demand. Growth in international bookings and strategic investments underpin a confident outlook.

Dalrymple Bay Infrastructure Limited forecasts a 3.6% increase in terminal charges and a 6.5% uplift in distributions for the 2025/26 financial year, confirming steady growth and full terminal capacity.

Regis Resources reports a solid increase in Mineral Resources and Ore Reserves for 2024, driven by significant underground growth at Duketon and Tropicana. Exploration success at key sites underpins confidence in extending mine life and expanding underground operations.

EDU Holdings Limited plans to voluntarily delist from the ASX, citing low share liquidity and regulatory uncertainty in the international student market. The company proposes a substantial buy-back offer to provide shareholders with an exit opportunity ahead of delisting.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.

Botanix Pharmaceuticals clarifies its lead product Sofdra is unlikely to face price cuts under the proposed US executive order on drug pricing, citing its exclusive US market approval and distinct formulations abroad.

EDU Holdings reports a 25% increase in total student enrolments for Term 2, 2025 at its Australian Learning Group, even as new enrolments decline amid tighter visa restrictions.

SomnoMed Limited reported a robust 23.2% revenue increase in Q3 FY25, reaffirming its full-year guidance while actively addressing new US tariffs through potential duty-free exemptions.

Carbonxt Group advances commissioning of its Kentucky activated carbon plant while securing $2.5 million in fresh capital and reporting strong sales growth and cost savings ahead of FY26.

Donaco International reported a modest revenue and EBITDA decline in Q3 FY2025 but strengthened its cash reserves. Meanwhile, the company agreed to a full acquisition scheme at a significant premium, setting the stage for shareholder decisions amid regulatory uncertainties.